Author Note Correspondence regarding this article should be addressed to Amy Neugebauer, Executive Director and Founder, The Giving Square, 5237 River Road, Suite #244, Bethesda, MD 20816. E-mail: [email protected] Children Are Undiscovered Community Assets Square partners with schools organizations develop children’s philanthropic skills, identities, tools. Square’s flagship program, […]

Hematol Transfus Int J 2017, 4(2): 00078 those using the anti-coagulant agent, warfarin [4,5]. One case of a patient undergoing coronary artery bypass grafting was noted among 7cases of surgery-associated acquired hemophilia [2]. A 66-year-old man underwent aortic valve replacement for severe aortic valve stenosis. After surgery, he was administered warfarin (2mg/day) for anticoagulation and th...

Acquired factor VIII deficiency is very rare, often fatal. It is associated with pregnancy, autoimmune diseases, malignancy, and drugs, although no underlying cause is found in 50%. A 49-year-old male was referred with right shoulder bruising. The coagulation test showed a prolonged activated partial thromboplastin time. The factor VIII level was less than 1%, and the factor VIII inhibitor anti...

BACKGROUND AND OVERVIEW This article reviews the literature on the subject of dental unit waterline contamination. It has been expanded from the text of a lecture given at the Scientific Frontiers in Dentistry program sponsored by the National Institute for Dental and Craniofacial Research in Bethesda, Md., in July 1999. The author examines the underlying biological causes of waterline coloniza...

Acquired hemophilia A (AHA) is a bleeding disorder caused by the development of an auto-antibody against endogenous factor VIII (FVIII). In this study, the epitope of the autoantibody was identified in a 67-year-old female patient with AHA. A prolonged activated partial thromboplastin time (77.4 s) that failed to correct in an incubation mixing test (68.2 s), a decreased FVIII activity, and a h...

Craniofacial Developmental Biology and Regeneration Branch, National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland, U.S.A.; *Center for Combat Casualty and Life Sustainment Research, Department of Pathology, USUHS, Bethesda, Maryland, U.S.A.; †Department of Biochemistry and Molecular Biology, The George Washington University School of Medicine and Health Sciences, Washi...

A report by an ad hoc Committee established by the Advisory Council for the National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20014. Reprint requests should be addressed to: Stroke Program, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20014.